Organism: Homo sapiens
Gene: 1553447_at
Selected probe(set): 1553447_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 1553447_at (1553447_at) across 6537 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):2.447423
Number of Samples:8 / 6

Experimental	myotonic dystrophy study 4 (skeletal muscle; DM2)
	Unspecified skeletal muscle biopsies obtained from patients with myotonic dystrophy type 2 (DM2).
Control	normal skeletal muscle tissue (adult)
	Commercially purchased normal adult skeletal muscle tissue samples.

Relative Expression (log2-ratio):2.2060862
Number of Samples:2 / 4

Experimental	OXPHOS disorder study 1 (middle)
	Skeletal muscle biopsies obtained from young patients (23 and 36 years old) with oxidative phosphorylation system deficiency (OXPHOS disorder). All patients exhibited mutations in the catalytic DNA polymerase gamma (POLG1) gene.
Control	control muscle (middle)
	Skeletal muscle biopsies obtained from control middle-aged subjects that were 17 to 34 years old.

Relative Expression (log2-ratio):2.1750412
Number of Samples:3 / 5

Experimental	necrotizing myopathy study 1
	Biceps femoris biopsy muscle samples from patients with clinical diagnosis of necrotizing myopathy (NM).
Control	inclusion body myositis study 1
	Biceps femoris biopsy muscle samples from patients with clinical diagnosis of inclusion body myositis (IBM).

Relative Expression (log2-ratio):2.1349144
Number of Samples:9 / 6

Experimental	myotonic dystrophy study 4 (biceps brachii; DM-like)
	Biceps brachii biopsies obtained from patients with myotonic-like dystrophy (DMx; DM-like; no DMPK or ZNF9 expansion).
Control	normal skeletal muscle tissue (adult)
	Commercially purchased normal adult skeletal muscle tissue samples.

Relative Expression (log2-ratio):2.0893126
Number of Samples:5 / 6

Experimental	myotonic dystrophy study 4 (skeletal muscle; DM1)
	Unspecified skeletal muscle biopsies obtained from patients with myotonic dystrophy type 1 (DM1).
Control	normal skeletal muscle tissue (adult)
	Commercially purchased normal adult skeletal muscle tissue samples.

Relative Expression (log2-ratio):2.0789309
Number of Samples:3 / 6

Experimental	myotonic dystrophy study 4 (biceps brachii; DM2)
	Biceps brachii biopsies obtained from patients with myotonic dystrophy type 2 (DM2).
Control	normal skeletal muscle tissue (adult)
	Commercially purchased normal adult skeletal muscle tissue samples.

Relative Expression (log2-ratio):1.815341
Number of Samples:20 / 6

Experimental	myotonic dystrophy study 2 (DM2)
	Muscle biopsies from patients with myotonic dystrophy type 2 (DM2). The disease was diagnosed by DNA mutation testing.
Control	normal skeletal muscle tissue
	Muscle biopsies from normal individuals.

Relative Expression (log2-ratio):1.714077
Number of Samples:10 / 6

Experimental	myotonic dystrophy study 2 (DM1)
	Muscle biopsies from patients with myotonic dystrophy type 1 (DM1). The disease was diagnosed by DNA mutation testing.
Control	normal skeletal muscle tissue
	Muscle biopsies from normal individuals.

Relative Expression (log2-ratio):1.680439
Number of Samples:3 / 6

Experimental	Becker muscular dystrophy study 3 (biceps brachii)
	Biceps brachii biopsies obtained from patients with Becker muscular dystrophy (BMD).
Control	normal skeletal muscle tissue (adult)
	Commercially purchased normal adult skeletal muscle tissue samples.

Relative Expression (log2-ratio):-1.5413103
Number of Samples:5 / 3

Experimental	polymyositis study 1
	Biceps femoris biopsy muscle samples from patients with clinical diagnosis of polymyositis (PM).
Control	necrotizing myopathy study 1
	Biceps femoris biopsy muscle samples from patients with clinical diagnosis of necrotizing myopathy (NM).